Heng Liu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Heng Liu has a total of 177 co-authors. Here are the top co-authors by number of shared publications:
- Fabiao Yu
Hainan Medical University
12 shared publications Shengfu Wang
Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials, Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules & College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430062, China
10 shared publicationsFengzao Chen
Department of Chemistry, Taizhou University, Jiaojiang 318000, PR China; College of Chemistry and Chemical Engineering, Hubei University, Wuhan 430062, PR China
6 shared publicationsHanping He
Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials, Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules & College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430062, China
6 shared publicationsWangbo Qu
Hubei Collaborative Innovation Center for Advanced Organic Chemical Materials, Ministry of Education Key Laboratory for the Synthesis and Application of Organic Functional Molecules & College of Chemistry and Chemical Engineering, Hubei University, Wuhan, 430062, China
6 shared publications- Xiuhua Zhang
Hubei University
6 shared publications
Latest Publications
- 23 September 2026
- Published by Elsevier in Biomaterials
- Vol. 338 (Pt A) , 124657
Antitumor immunotherapeutic nanoagents enable molecular-photoswitching-based dynamic regulation of enzymatic activity of IDO1 for blocking immune evasion
- 23 September 2026
- Published by Elsevier in Biomaterials
- Vol. 338 (Pt A) , 124657
Antitumor immunotherapeutic nanoagents enable molecular-photoswitching-based dynamic regulation of enzymatic activity of IDO1 for blocking immune evasion
- 26 April 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (18) , 13699-13706
Engineering an Activatable Near-Infrared Fluorogenic Probe for Hypochlorous Acid in Keloid Diagnosis and Therapeutic Evaluation
Keloid is a skin fibrosis disease characterized by continuous deposition of extracellular matrix and invasive expansion of the lesion. Hypochlorous acid (HOCl), an important member of the reactive oxygen family, has been proven to participate in the activation process of fibroblasts in various fibrosis diseases. However, the dynamic changes in keloid have not been fully explored. Herein, we constructed an activatable near-infrared fluorogenic (NIRF) probe DQFCl-HOCl for visualizing HOCl and exploring its association with the pathological activity of keloid. DQFCl-HOCl featured NIRF emission, rapid response, nanomolar-level detection sensitivity, and excellent selectivity. In cell models, DQFCl-HOCl could image exogenous and endogenous HOCl. More importantly, the HOCl fluorescence signal in keloid fibroblasts was markedly higher than that in normal dermal fibroblasts, and it decreased after intervention with RepSox or triamcinolone acetonide (TA). In a patient-derived xenograft model, DQFCl-HOCl could distinguish keloid tissue in mice and dynamically visualize the therapeutic effect of TA. Additionally, transcriptomic coexpression network analysis combined with Western blot results indicated that redox regulation pathways were closely coupled with the fibrotic signaling network centered on TGF-β. This work provided a new chemical imaging tool for tracing the redox microenvironment of keloid and evaluating therapeutic response.
- 26 April 2026
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 98 (18) , 13699-13706
Engineering an Activatable Near-Infrared Fluorogenic Probe for Hypochlorous Acid in Keloid Diagnosis and Therapeutic Evaluation
Keloid is a skin fibrosis disease characterized by continuous deposition of extracellular matrix and invasive expansion of the lesion. Hypochlorous acid (HOCl), an important member of the reactive oxygen family, has been proven to participate in the activation process of fibroblasts in various fibrosis diseases. However, the dynamic changes in keloid have not been fully explored. Herein, we constructed an activatable near-infrared fluorogenic (NIRF) probe DQFCl-HOCl for visualizing HOCl and exploring its association with the pathological activity of keloid. DQFCl-HOCl featured NIRF emission, rapid response, nanomolar-level detection sensitivity, and excellent selectivity. In cell models, DQFCl-HOCl could image exogenous and endogenous HOCl. More importantly, the HOCl fluorescence signal in keloid fibroblasts was markedly higher than that in normal dermal fibroblasts, and it decreased after intervention with RepSox or triamcinolone acetonide (TA). In a patient-derived xenograft model, DQFCl-HOCl could distinguish keloid tissue in mice and dynamically visualize the therapeutic effect of TA. Additionally, transcriptomic coexpression network analysis combined with Western blot results indicated that redox regulation pathways were closely coupled with the fibrotic signaling network centered on TGF-β. This work provided a new chemical imaging tool for tracing the redox microenvironment of keloid and evaluating therapeutic response.
- Open Access
- 27 March 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103077
A photocuring double-network hydrogel enhances mechanotransduction and scavenges ROS to accelerate pressure injury healing
- 27 March 2026
- Published by Elsevier in Materials Today Bio
- Vol. 38, 103077
Open AccessA photocuring double-network hydrogel enhances mechanotransduction and scavenges ROS to accelerate pressure injury healing
- 29 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (4) , 2215-2228
Core–Shell Type Nanoagent Enables Phototriggered Synergistic Antitumor Activity via Chlorine Radical-Induced and Nitric Oxide-Enhanced Oxidative Damage
Chlorine radical (•Cl) has shown great promise as an active species for enhancing oxidative stress in antitumor therapy. Herein, a core-shell type of nanoagent (mSU@A-NPs@F-R) capable of destroying cancer cells via the synergistic effect between two photogenerated active species, chlorine radical (•Cl) and nitric oxide (NO), was developed with the crucial involvement of upconversion nanoparticles (UCNPs), AgCl nanoparticles, and l-arginine. The mSU@A-NPs@F-R is photoactivated through the ability of UCNPs to upconver near-infrared (NIR) light into ultraviolet (UV) light, which subsequently mediates the generation of •Cl and Ag atoms. Additionally, Ag atoms mediate the release of NO from l-arginine, while NO promotes the generation of •Cl by acidifying the microenvironment. It is expected that the •Cl species induces oxidative damage to vital cellular components, including DNA backbone and mitochondrial membrane, while NO stabilizes oxidative damage of DNA and exacerbates mitochondrial injury. The high-performance therapeutic efficacy of mSU@A-NPs@F-R nanoagents, based on the aforementioned •Cl-induced oxidative damage to nuclear DNA and mitochondria combined with the NO-based fixation effect, was unequivocally demonstrated in tumor cell lines in vitro and cell-derived tumor xenograft (CDX) models in vivo.
- 29 January 2026
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 9 (4) , 2215-2228
Core–Shell Type Nanoagent Enables Phototriggered Synergistic Antitumor Activity via Chlorine Radical-Induced and Nitric Oxide-Enhanced Oxidative Damage
Chlorine radical (•Cl) has shown great promise as an active species for enhancing oxidative stress in antitumor therapy. Herein, a core-shell type of nanoagent (mSU@A-NPs@F-R) capable of destroying cancer cells via the synergistic effect between two photogenerated active species, chlorine radical (•Cl) and nitric oxide (NO), was developed with the crucial involvement of upconversion nanoparticles (UCNPs), AgCl nanoparticles, and l-arginine. The mSU@A-NPs@F-R is photoactivated through the ability of UCNPs to upconver near-infrared (NIR) light into ultraviolet (UV) light, which subsequently mediates the generation of •Cl and Ag atoms. Additionally, Ag atoms mediate the release of NO from l-arginine, while NO promotes the generation of •Cl by acidifying the microenvironment. It is expected that the •Cl species induces oxidative damage to vital cellular components, including DNA backbone and mitochondrial membrane, while NO stabilizes oxidative damage of DNA and exacerbates mitochondrial injury. The high-performance therapeutic efficacy of mSU@A-NPs@F-R nanoagents, based on the aforementioned •Cl-induced oxidative damage to nuclear DNA and mitochondria combined with the NO-based fixation effect, was unequivocally demonstrated in tumor cell lines in vitro and cell-derived tumor xenograft (CDX) models in vivo.
- Open Access
- 23 January 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102845
Unveiling aucubin-mediated inhibition of PANoptosis in lower limb ischemia-reperfusion injury with a near-infrared H2O2 fluorogenic probe
- 23 January 2026
- Published by Elsevier in Materials Today Bio
- Vol. 37, 102845
Open AccessUnveiling aucubin-mediated inhibition of PANoptosis in lower limb ischemia-reperfusion injury with a near-infrared H2O2 fluorogenic probe
- Open Access
- 2 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (2) , 1151-1156
Engineering ε -polylysine-based photodynamic therapy agents with oxygen carrying and membrane-targeting capabilities for enhanced therapy under hypoxic conditions
Photodynamic therapy (PDT) offers exceptional spatial and temporal precision, minimal invasiveness, and negligible side effects.
- 2 January 2026
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (2) , 1151-1156
Open AccessEngineering ε -polylysine-based photodynamic therapy agents with oxygen carrying and membrane-targeting capabilities for enhanced therapy under hypoxic conditions
Photodynamic therapy (PDT) offers exceptional spatial and temporal precision, minimal invasiveness, and negligible side effects.
- 20 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (48) , 26599-26606
Near-Infrared Fluorogenic Probe Enables Real-Time Imaging of HOCl to Reveal MAR1-Mediated Suppression of Pyroptosis in Limb Ischemia-Reperfusion Injury
The interplay between oxidative stress and programmed cell death plays a pivotal role in the development of several inflammation-related diseases. As one of the important reactive oxygen species (ROS) in living organisms, the specific function of hypochlorous acid (HOCl) in pyroptosis, as well as lower limb ischemia-reperfusion injury (LL-IRI), has not been fully explored. Herein, we fabricated an activatable near-infrared fluorogenic (NIRF) probe, BFP-HOCl, which enabled the highly selective and sensitive detection of HOCl. In the presence of HOCl, the fluorescence of BFP-HOCl was remarkably enhanced at 652 nm and exhibited a good linear response relationship. Using BFP-HOCl, imaging of exogenous and endogenous HOCl in cells was successfully achieved. Intriguingly, BFP-HOCl was able to track the elevated HOCl levels during LPS+ATP-induced pyroptosis and its fluorescence enhancement could be suppressed by MAR1 dose-dependently. In a mouse LL-IRI model, a combination of transcriptomic analysis, immunohistochemistry, qPCR, and in vivo imaging revealed a critical role for HOCl as an oxidative activator upstream of the ROS-NLRP3-GSDMD signaling axis. MAR1 effectively attenuated the degree of tissue injury by downregulating the level of HOCl and inhibiting the expression of pyroptosis-associated proteins (NLRP3, ASC, Caspase-1, and GSDMD). This work not only established that HOCl could be used as a potential marker of pyroptosis and LL-IRI but also further confirmed the functional status of pyroptosis in LL-IRI and the intervention potential of MAR1, which provided a new strategy for the diagnosis and intervention of LL-IRI.
- 20 November 2025
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 97 (48) , 26599-26606
Near-Infrared Fluorogenic Probe Enables Real-Time Imaging of HOCl to Reveal MAR1-Mediated Suppression of Pyroptosis in Limb Ischemia-Reperfusion Injury
The interplay between oxidative stress and programmed cell death plays a pivotal role in the development of several inflammation-related diseases. As one of the important reactive oxygen species (ROS) in living organisms, the specific function of hypochlorous acid (HOCl) in pyroptosis, as well as lower limb ischemia-reperfusion injury (LL-IRI), has not been fully explored. Herein, we fabricated an activatable near-infrared fluorogenic (NIRF) probe, BFP-HOCl, which enabled the highly selective and sensitive detection of HOCl. In the presence of HOCl, the fluorescence of BFP-HOCl was remarkably enhanced at 652 nm and exhibited a good linear response relationship. Using BFP-HOCl, imaging of exogenous and endogenous HOCl in cells was successfully achieved. Intriguingly, BFP-HOCl was able to track the elevated HOCl levels during LPS+ATP-induced pyroptosis and its fluorescence enhancement could be suppressed by MAR1 dose-dependently. In a mouse LL-IRI model, a combination of transcriptomic analysis, immunohistochemistry, qPCR, and in vivo imaging revealed a critical role for HOCl as an oxidative activator upstream of the ROS-NLRP3-GSDMD signaling axis. MAR1 effectively attenuated the degree of tissue injury by downregulating the level of HOCl and inhibiting the expression of pyroptosis-associated proteins (NLRP3, ASC, Caspase-1, and GSDMD). This work not only established that HOCl could be used as a potential marker of pyroptosis and LL-IRI but also further confirmed the functional status of pyroptosis in LL-IRI and the intervention potential of MAR1, which provided a new strategy for the diagnosis and intervention of LL-IRI.